Allied Biotech Corporation (TPEX:1780)
31.85
-0.15 (-0.47%)
At close: May 8, 2026
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 3.07 billion as of May 8, 2026. Its market cap has increased by 94.65% in one year.
Market Cap
3.07B
Enterprise Value
2.94B
Revenue
849.51M
Ranking
n/a
PE Ratio
23.77
Stock Price
31.85
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 3.07B, an increase of 140.52%. That is a compound annual growth rate of 5.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.07B | 37.88% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.87B |
| SCI Pharmtech | 5.65B |
| Easywell Biomedicals | 4.51B |
| Orient EuroPharma | 4.04B |
| Merdury Biopharmaceutical | 3.37B |
| Maywufa Company | 2.89B |
| Johnson Chemical Pharmaceutical Works | 2.47B |
| PhytoHealth | 2.38B |